Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AstraZeneca
Biotech
AZ hopes for ‘amazing things’ from Kendall Square R&D center
AstraZeneca execs touted the benefits of embedding themselves in Massachusetts’ biopharma “ecosystem” as the Big Pharma opened a new R&D center.
Julia Sklar
Oct 6, 2026 5:30am
AstraZeneca scales Summit’s PD-1xVEGF combos with $2B investment
Sep 29, 2026 3:07am
Artelo cannabinoid agonist holds its own against semaglutide
Sep 18, 2026 2:22pm
DPHARM: Where to begin with AI in clinical trials?
Sep 18, 2026 12:10pm
DPHARM: How to address the clinical trial enrollment crisis?
Sep 17, 2026 11:52am
Owkin, Servier ink oncology trial and discovery deal
Sep 11, 2026 2:01pm
